Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/1995
06/15/1995WO1995015749A1 Cysteine protease inhibitors containing heterocyclic leaving groups
06/15/1995WO1995014233A3 Method of identifying hdm-2-specific antibodies
06/15/1995WO1995014100A3 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting
06/15/1995WO1995014089A3 Cck-2, a receptor tyrosine kinase
06/15/1995WO1995013297A3 Improved immunogenic compositions against human gastrin 17
06/15/1995WO1995012678A3 Improvements relating to cancer therapy
06/15/1995WO1995011980A3 PLASMIDS FOR EFFICIENT EXPRESSION OF SYNTHETIC GENES IN $i(E. COLI)
06/15/1995WO1995011974A3 Human peroxisome proliferator activated receptor
06/15/1995CA2178729A1 Compounds and methods for site-directed mutations in eukaryotic cells
06/15/1995CA2178477A1 Pretargeting methods and compounds
06/15/1995CA2178476A1 Pretargeting methods and compounds
06/15/1995CA2178345A1 Novel synthetic peptide, lung surfactant containing the same, and remedy for respiratory distress syndrome
06/15/1995CA2178205A1 Method of selecting specific bacteriophages
06/15/1995CA2177840A1 Cs-1 peptidomimetics, compositions and methods of using the same
06/15/1995CA2177835A1 Methods and compositions for the suppression of neu mediated transformation
06/15/1995CA2177495A1 Cysteine protease inhibitors containing heterocyclic leaving groups
06/15/1995CA2177471A1 Ifn-.gamma.receptor .beta.-chain and derivatives thereof
06/15/1995CA2177464A1 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope
06/15/1995CA2176825A1 C5a receptor antagonists having substantially no agonist activity
06/14/1995EP0657541A1 Novel entities for cancer therapy
06/14/1995EP0657540A1 Novel entities for cancer therapy
06/14/1995EP0657539A1 Novel entities for cancer therapy
06/14/1995EP0657536A1 Proteases capable of shedding the soluble TNF-receptor and TNF-R derived peptides and antibodies against the proteases inhibiting the shedding
06/14/1995EP0657534A1 Antiallergic agent
06/14/1995EP0657532A1 HIV-3 retrovirus strains and their use
06/14/1995EP0657470A2 Monoclonal antibodies against in vivo glycated albumin
06/14/1995EP0657469A1 L-Selectin cleavage site, methods of diagnosis and usage thereof
06/14/1995EP0657468A1 Human stromae derived factor
06/14/1995EP0657467A1 Antitumor antibiotics
06/14/1995EP0657175A2 Vaccine comprising autologous epidermal growth factor and use thereof
06/14/1995EP0657029A1 Calcium receptor active molecules
06/14/1995EP0656952A1 Cationic peptides and method for production
06/14/1995EP0656950A1 Tat-derived transport polypeptides
06/14/1995EP0656949A1 Vaccinia virus b15r used in interleukin b1-involving condition
06/14/1995EP0656948A1 $i(BORDETELLA BRONCHISEPTICA) VACCINE
06/14/1995EP0656947A1 Human interleukin-13
06/14/1995EP0656946A1 Immunoglobulins devoid of light chains
06/14/1995EP0656945A1 Stress protein epitopes
06/14/1995EP0656944A1 Human melanocyte stimulating hormone receptor
06/14/1995EP0656943A1 Fungal promoters active in the presence of glucose
06/14/1995EP0656941A1 Methods for producing members of specific binding pairs
06/14/1995EP0656908A1 Use of specific binding molecules in potentiating igf-i activity
06/14/1995EP0656907A1 Conformationally restricted mimetics of reverse turns and peptides containing the same
06/14/1995EP0656906A1 A novel endothelial cell molecule mediating lymphocyte binding in man
06/14/1995EP0656904A1 Peptide inhibitors of selectin binding
06/14/1995EP0656903A1 Methods and compositions for the identification, characterization, and inhibition of farnesyltransferase
06/14/1995EP0656790A1 Compositions and methods for modulating rna
06/14/1995EP0656788A1 Hla binding peptides and their uses
06/14/1995EP0656785A1 Method for inhibiting hiv replication using il-4
06/14/1995EP0656784A1 Parathyroid hormone fragments and analogs
06/14/1995EP0656747A1 Composition and method for altering dna sequences by homologous recombination
06/14/1995EP0585310A4 Crosstalk inhibitors and their uses.
06/14/1995EP0583352A4 -i(IN VITRO) METHODS FOR DETERMINING -i(IN VIVO) THROMBOTIC EVENTS.
06/14/1995EP0494260B1 Granulocyte-colony stimulating factor receptors
06/14/1995EP0458841B1 Method for the use and synthesis of peptides
06/14/1995DE4339533A1 Detection of human double minute gene 2 (hdm-2) antibodies
06/14/1995DE4338817A1 Gene sequences for cellular X binding proteins isolated from mouse
06/13/1995US5424412 Construct comprising a promoter, a non-translated leader, and a 3'non-translated sequence that functions to cause addition of polyadenylated nucleotides to 3' end of RNA sequence
06/13/1995US5424410 A culture product DNA encoding an endotoxins as miticides, pesticides
06/13/1995US5424409 DNA constructs encoding Bacillus thuringiensis toxins from strain A20
06/13/1995US5424408 For detection, removal of Goodpasture antibodies in blood; autoimmune diseases
06/13/1995US5424401 Absorbing enzymatic impurities which has amidolytic and proteolytic activity which degrade the blood factor 8, by pretreating with a solution containg aluminum hydroxide and basic ion exchange resin as absorbents
06/13/1995US5424400 Senescent cell derived inhibitors of DNA synthesis
06/13/1995US5424399 Recombinant heterodimer comprising extracellular domains of human complement receptor type 3 alpha and beta; inhibits CR3-mediated immune response
06/13/1995US5424398 A polypeptide supporting with a solid as antibody inhibitor
06/13/1995US5424396 Containing three to six amino acids
06/13/1995US5424395 Antimicrobial peptides active against plant pathogens
06/13/1995US5424394 Synthetic preparation of amylin and amylin analogues
06/13/1995US5424290 Amphiphilic polypeptide containing 21 to 26 amino acids inhibits growth of target cells, viruses and virally-infected cells
06/13/1995US5424287 A pure protein-based extract prepared by alkaline extraction a bacterial suspension at a PH between 11 to 13; stimulants for production of prostaglandins, anticarcinogenic agents; immunology
06/13/1995US5424286 Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
06/13/1995US5424218 Measuring binding affinity of compound to omega conotoxin binding site and ability to inhibit voltage-gated calcium currents or neurotransmitter release
06/13/1995US5424199 Human growth hormone
06/13/1995US5424191 Epithelial cell specific differentiation marker
06/13/1995US5424185 Human high-affinity neurotransmitter uptake system
06/13/1995US5424068 Isolation of low density lipoproteins from blood, fusing them to form heavy microemulsion particles having new antigenic properties, injecting fusion particles back into mammal to remove heavy particles from atherosclerotic lesions
06/13/1995US5424065 Comprising mutant Salmonella
06/13/1995CA1335925C Process for recovering microbially produced interleukin-2
06/13/1995CA1335924C Mixed crystals of insulin and insulin derivatives, a process for the preparation of these mixed crystals, pharmaceutical agents containing these mixed crystals, and the use thereof for the treatment of diabetes mellitus
06/13/1995CA1335883C Enhancement of the cellular immune response
06/13/1995CA1335882C Process for preparing human factor viii:c employing expression vector containing chick _ -actin promoter
06/13/1995CA1335879C Receptor membranes
06/10/1995CA2137206A1 Glucagon-like insulinotropic peptides, compositions and methods
06/09/1995EP0724646A4 Dna sequences related to isolated fragile x syndrome
06/09/1995CA2136590A1 Recombinant genes expressing pp14
06/08/1995WO1995015495A1 Prenatal detection of meconium
06/08/1995WO1995015396A1 ENTEROTOXINS OF SHIGELLA FLEXNERI 2a
06/08/1995WO1995015392A1 Chimeric geens and methods for increasing the lysine content of the seeds of corn, soybean and rapeseed plants
06/08/1995WO1995015389A2 Promoter
06/08/1995WO1995015384A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
06/08/1995WO1995015383A2 Biological control agents
06/08/1995WO1995015382A1 Binding structures directed against the ca55.1 antigen
06/08/1995WO1995015381A2 HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER
06/08/1995WO1995015380A1 Rna polymerase transcription factor
06/08/1995WO1995015379A1 Chicken oocyte receptor p95 (vldl/vtg receptor)
06/08/1995WO1995015377A1 Plant arabinogalactan protein (agp) genes
06/08/1995WO1995015376A2 IN VIVO ASSAYS FOR INHIBITORS OF IgE MEDIATED ALLERGIC RESPONSES
06/08/1995WO1995015375A1 NOVEL Eph-RELATED TYROSINE KINASES, NUCLEOTIDE SEQUENCES AND METHODS OF USE
06/08/1995WO1995015341A1 Antibody against carcinoembryonic antigen (cea)
06/08/1995WO1995015339A1 Antagonists to chaperonin 10
1 ... 2596 2597 2598 2599 2600 2601 2602 2603 2604 2605 2606 2607 2608 2609 2610 2611 2612 2613 2614 2615 2616 ... 2916